Our current researches focus on innate lymphoid cells in mouse lungs. We are investigating the regulation of group 2 innate lymphoid cell functions, their interaction with other cells and their role in allergic lung inflammation
Dr. Takei received his PhD from the University of British Columbia (UBC) and completed postdoctoral training in Cambridge, England. He then returned to UBC to lead his own laboratory. He has been working on innate lymphocytes for over 30 years. From 1990 to 2010, he mainly worked on natural killer (NK) cell receptors for MHC class I and regulation of NK cell functions and development. In 2010, he found a unique lymphocyte population, which is now termed group 2 innate lymphoid cell (ILC2), in mouse lungs. He showed that lung ILC2s play a key role in allergic lung inflammation. He is currently investigating the regulation of ILC2 functions and functional and developmental relationship between ILC2s and other lymphocytes.
Professor, Pathology & Laboratory Medicine, University of British Columbia
Professor, Pathology & Laboratory Medicine, University of British Columbia (UBC)
Associate Member, Medical Genetics, University of British Columbia (UBC)
Associate Member, Microbiology, University of British Columbia (UBC)